Food and Drug Administration

Arthritis Advisory Committee

September 30, 2003

Slides

Trial Design Issues in SLE, Joel Schiffenbauer, FDA (HTM) (PPT)

Steroid-Sparing Ability of Agents in SLE, Dr. Matthew Liang, MD, FDA (HTM) (PPT)